Abstract

The first general [18F]AIF automated radiolabelling procedure developed on the GE Tracerlab FX FN (Left) and Trasis AllInOne (Right) platforms.

Highlights

  • Positron emission tomography (PET) is an imaging modality used to diagnose and stage diseases by quantitatively monitoring the in vivo distribution of a positron emitting radionuclide bound by chelation or covalent bonding to a biological targeting molecule

  • Automated processes are typically required for the production of good manufacturing process (GMP) compliant fluorine-18 radiopharmaceuticals

  • Automation of radiopharmaceutical production is desirable to reduce the risk to patients by enabling batch reporting/record keeping, management control and standardisation of processes through the use of standard operating practices (SOPs)

Read more

Summary

Introduction

Positron emission tomography (PET) is an imaging modality used to diagnose and stage diseases by quantitatively monitoring the in vivo distribution of a positron emitting radionuclide bound by chelation or covalent bonding to a biological targeting molecule. PET radioisotope due to a combination of its high positron emission (97%), low positron energy (β + max = MeV). Investigation into the direct radiolabelling of biomolecules with fluorine-18 yielded a one-step procedure comprising the chelation of the aluminium fluoride-18 complex ([18F]AlF) by a macrocyclic ligand (i.e. NOTA, NODA).[4,5,6,7]. The rapid [18F]AlF technique has generated significant interest owing to the combination of convenient metal based radiochemistry and the excellent decay characteristics of fluorine-

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.